OMGA Logo

Omega Therapeutics, Inc. (OMGA) 

NASDAQ
Market Cap
$60.39M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
652 of 776
Rank in Industry
355 of 433

Largest Insider Buys in Sector

OMGA Stock Price History Chart

OMGA Stock Performance

About Omega Therapeutics, Inc.

Omega Therapeutics, Inc. operates as a development-stage biopharmaceutical company. Its OMEGA Epigenomic Programming platform is designed to coopt nature's operating system by harnessing the power of epigenetics, the mechanism for gene control and cell differentiation. The company is developing omega epigenomic controller (OEC) candidates to up-regulate the expression of HNF4a, a transcriptional master regulator as a potential way to restore liver-cell function in patients suffering from chronic liver diseases; to control the expression of …

Insider Activity of Omega Therapeutics, Inc.

Over the last 12 months, insiders at Omega Therapeutics, Inc. have bought $0 and sold $0 worth of Omega Therapeutics, Inc. stock.

On average, over the past 5 years, insiders at Omega Therapeutics, Inc. have bought $28.12M and sold $220,000 worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 3,323,310 shares for transaction amount of $19.21M was made by Flagship Pioneering Inc. (10 percent owner) on 2023‑02‑27.

List of Insider Buy and Sell Transactions, Omega Therapeutics, Inc.

2023-06-02Saledirector
5,000
0.0098%
$8.00$40,000-59.06%
2023-05-01Saledirector
5,000
0.0097%
$8.00$40,000-56.17%
2023-04-06Saledirector
5,000
0.0102%
$8.00$40,000-52.52%
2023-03-17Saledirector
10,000
0.0162%
$8.00$80,000-60.53%
2023-02-27Purchase10 percent owner
3.32M
6.508%
$5.78$19.21M-31.56%
2023-01-10Saledirector
20,000
0.0383%
$8.00$160,000-36.67%
2022-09-14Saledirector
10,000
0.0251%
$8.00$80,000-7.14%
2021-08-03Purchase10 percent owner
1.18M
3.7637%
$17.00$20M-32.01%
2021-08-03Purchase10 percent owner
875,000
2.7992%
$17.00$14.88M-32.01%
2021-08-03Purchasedirector
53,082
0.1698%
$17.00$902,394-32.01%
2021-08-03PurchaseChief Financial Officer
2,941
0.0094%
$17.00$49,997-32.01%
2021-07-30Purchase10 percent owner
75,000
0.2342%
$16.14$1.21M-29.19%

Insider Historical Profitability

<0.0001%
Flagship Pioneering Inc.10 percent owner
7508693
13.6138%
$1.1020<0.0001%
Invus Public Equities, L.P.10 percent owner
2273530
4.1221%
$1.1020<0.0001%
BERRY DAVID Adirector
53082
0.0962%
$1.1010<0.0001%
Sawhney RogerChief Financial Officer
2941
0.0053%
$1.1010<0.0001%

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Flagship Pioneering$106.67M52.9929.23M0%+$07
Fidelity Investments$22.97M11.416.29M+19.04%+$3.67M<0.01
HarbourVest Partners$12.82M6.373.51M0%+$05.85
State of Wisconsin Investment Board$6.78M3.371.86M0%+$00.02
BlackRock$5.17M2.571.42M+2.4%+$120,990.22<0.0001
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.